Severe respiratory disease concurrent with the circulation of H1N1 influenza

Gerardo Chowell1, Stefano M Bertozzi, M Arantxa Colchero

  • 1Division of Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.

Abstract

Insights

The 2009 swine flu pandemic disproportionately affected younger adults, causing severe pneumonia in those aged 5-59. This age shift suggests prior exposure may offer protection, guiding future prevention efforts.

Area of Science:

  • Epidemiology
  • Virology
  • Public Health

Background:

  • A novel swine-origin influenza A (H1N1) virus (S-OIV) caused a severe pneumonia outbreak in Mexico in 2009.
  • Influenza A (H1N1) viruses had not predominated since the 1957 pandemic.
  • Analyzing this epidemic provides insights into risk factors and control of severe H1N1 disease.

Purpose of the Study:

  • To analyze the demographic and clinical features of the 2009 H1N1 influenza pandemic in Mexico.
  • To compare the age distribution of severe pneumonia cases during the H1N1 outbreak with historical influenza epidemics.
  • To identify risk factors and guide control strategies for H1N1-related severe pneumonia.

Main Methods:

  • Retrospective analysis of severe pneumonia cases reported to the Mexican Ministry of Health from March 24 to April 29, 2009.
  • Testing of nasopharyngeal specimens for S-OIV at the National Epidemiological Reference Laboratory.
  • Comparison of the age distribution of severe pneumonia and mortality during the H1N1 epidemic with data from previous influenza seasons.

Main Results:

  • During the study period, 2155 severe pneumonia cases, 821 hospitalizations, and 100 deaths were reported.
  • S-OIV was detected in 2582 of 8817 submitted specimens.
  • A significant shift in age distribution was observed: 87% of deaths and 71% of severe pneumonia cases occurred in individuals aged 5-59 years, contrasting with historical averages.

Conclusions:

  • The 2009 H1N1 pandemic exhibited an unusual age distribution, affecting a younger population compared to typical influenza epidemics.
  • This age shift suggests potential cross-protective immunity from prior exposure to H1N1 strains before 1957.
  • Findings support prioritizing younger populations for H1N1 prevention efforts, especially if resources like vaccines are limited.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.8K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
828
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
773
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
101
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
58